THE Overall Objective of This Contract IS to Advance the Development of the Reveal Rapid AST System AS an Antibiotic Susceptibility Diagnostic Test Type of Countermeasure to Determine the Treatment for Life Threatening Urgent Infections From Patient
Contract Overview
Contract Amount: $7,625,622 ($7.6M)
Contractor: Biofire Defense LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2022-09-30
End Date: 2025-12-17
Contract Duration: 1,174 days
Daily Burn Rate: $6.5K/day
Official Description: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF THE REVEAL RAPID AST SYSTEM AS AN ANTIBIOTIC SUSCEPTIBILITY DIAGNOSTIC TEST TYPE OF COUNTERMEASURE TO DETERMINE THE TREATMENT FOR LIFE THREATENING URGENT INFECTIONS FROM PATIENT
Place of Performance
Location: Utah, 84107
State: Utah Government Spending